Outcomes of the study combining necitumumab and abemaciclib in patients with NSCLC

Benjamin Besse, MD, PhD from the Institute Gustave Roussy, Villejuif, France, discusses the outcomes of the recent phase 1b study of necitumumab in combination with abemaciclib in patients with stage ... Author: VJHemOnc Added: 05/17/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts